Organogenesis Holdings (ORGO) Cash from Investing Activities (QoQ) (2018 - 2026)
Organogenesis Holdings (ORGO) Cash from Investing Activities (QoQ) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn |
| 3 | Zoetis | 31.45 Bn | 29.77 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.23 Bn | 19.57 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.47 Bn | 15.08 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.70 Bn | 11.17 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - |
| 10 | Organogenesis Holdings | 239.33 Mn | 192.49 Mn | 20.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 65.03% |
| Mar 31, 2026 | 32.37% |
| Dec 31, 2025 | -108.14% |
| Sep 30, 2025 | 38.57% |
| Jun 30, 2025 | -0.33% |
| Mar 31, 2025 | -7.88% |
| Dec 31, 2024 | -30.83% |
| Sep 30, 2024 | -36.65% |
| Jun 30, 2024 | 15.39% |
| Mar 31, 2024 | 33.15% |
| Dec 31, 2023 | 44.41% |
| Sep 30, 2023 | 20.27% |
| Jun 30, 2023 | 0.83% |
| Mar 31, 2023 | 29.04% |
| Dec 31, 2022 | -2.44% |
| Sep 30, 2022 | -68.64% |
| Jun 30, 2022 | 7.55% |
| Mar 31, 2022 | -27.64% |
| Dec 31, 2021 | 68.71% |
| Sep 30, 2021 | -285.48% |